10 Biotech Trades for Second Half of 2011

Description:

According to Adam Feuerstein, "The biotech calendar for the second half of 2011 is filled with drug approval decisions and clinical trial outcomes, enough to keep biotech stocks jumping for the remainder of the year." Read more here.

>>Also: 10 Cheap Biotech Stocks That Could Soar

>>Also: 5 Dow Stocks Likely to Rise After Earnings

Portfolio not tracked.

Most Viewed Portfolios

View All

Articles

Must-See Charts: 5 Big Stocks to Sidestep the Selloff

09.23.14 | 09:47 AM

BALTIMORE (Stockpickr) -- Yesterday was an ugly day for stocks -- and not because of the 0.8% drop in the S&P 500. Even though that drop wasn't pre...

4 Health Care Stocks Triggering Breakout Trades on Unusual Volume

09.23.14 | 08:35 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter